User
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec GmbH
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach
Germany
Phone: +49 2204 8306-0
Fax: +49 2204 85197
E-Mail: macs@miltenyibiotec.de
Web: www.miltenyibiotec.com
For immediate technical support, use our live chat. Connect with us
Orders
Phone: +49 2204 8306-20
Fax: +49 2204 8306-235
E-Mail: macsorders@miltenyibiotec.de
Technical support - Research products
Phone: +49 2204 8306-830
Fax: +49 2204 8306-89
E-Mail: macstec@miltenyibiotec.de
Technical support - Clinical products
Phone: +49 2204 8306-8484
Fax: +49 2204 8306-89
E-Mail: macstec@miltenyibiotec.de
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Thursday, July 5 – Friday, July 6, 2018
Centre de Recherche des Cordeliers (CRC)
Campus des Cordeliers – Amphithéâtre Farabeuf
15 rue de l’école de médecine, 75006 Paris
Thursday, July 5 | |
| 08:30 a.m. | Opening
Daniel Louvard, France |
08:45 a.m. | Heterogeneity of immune cells and cancer antigens in cancer vaccines and immunotherapy: mouse models and translation to human clinical trials (EATI Honorary Lecture 2018)
Jay A. Berzofsky, USA |
| 09:30 a.m. | Host-Microbiome interactions – reality or myth? Harry Sokol, France |
10:00 a.m. | Programming tissue residency to enhance immunity to infection and tumors Ananda W. Goldrath, USA |
| 10:30 a.m. | Coffee break |
11:00 a.m. | Immunotherapy of cancer: clinical experimentation Fabrice André, France |
11:30 a.m. | From initiation to treatment: microbial influences in carcinogenesis Christian Jobin, USA |
| 12:00 p.m. | Lunch break |
| 02:00 p.m. | Defining molecular identity of intratumoral T cells to design better cancer immunotherapies Sergio Abrignani, Italy |
02:30 p.m. | Molecular and epigenetic programs defining tumor-specific T cell dysfunction Andrea Schietenger, USA |
03:00 p.m. | Immune parameters for predicting patient outcome Christian Ottensmeier, UK |
03:30 p.m. | Coffee break |
04:00 p.m. | IL-18 drives immunosuppression in multiple myeloma Ludovic Martinet, France |
04:30 p.m. | Induction and transcriptional regulation of the “co-inhibitory” gene module in T cells Vijay Kuchroo, USA |
| 5:00 p.m. | Celebration party “20th Year Miltenyi Biotec France” |
Friday, July 6 | |
09:15 a.m. | Welcome Laurence Zitvogel / Guido Kroemer / Hervé Fridman, France |
09:30 a.m. | The role of GM-CSF in graft-vs-host disease: uncoupling of GvHD and GvL immunity Burkhardt Becher, Switzerland |
10:00 a.m. | Myeloid cells contribution to tumor outcome Miriam Merad, USA |
10:30 a.m. | Coffee break |
11:00 a.m. | Genetic screens to identify immunotherapy targets Nicholas Haining, USA |
11:30 a.m. | Cancer evolution and immune escape: TRACERx Rachel Rosenthal, UK |
12:00 p.m. | Lunch break |
02:00 p.m. | Dynamics of epigenetic traits in triple-negative breast cancer Céline Vallot, France |
02:30 p.m. | Single-cell transcriptomic network inference as a new approach to better characterize autoinflammatory diseases Mickaël Ménager, France |
03:00 p.m. | Molecular basis of T cell exhaustion: insights for immunotherapy E. John Wherry, USA |
03:30 p.m. | Coffee break |
04:00 p.m. | Metabolic interventions for the immunoprophylaxis of breast cancer Guido Kroemer, France |
04:30 p.m. | Closing / Farewell Jean Magon, France |
For any questions, please send an e-mail to macs@miltenyibiotec.fr or call +33 1 56 98 16 16.
Download PDF
Play video